Cytochrome b5 deficiency explained

Specialty:endocrinology

Cytochrome b5 deficiency is a rare condition and form of isolated 17,20-lyase deficiency caused by deficiency in cytochrome b5, a small hemoprotein that acts as an allosteric factor to facilitate the interaction of CYP17A1 (17α-hydroxylase/17,20-lyase) with P450 oxidoreductase (POR), thereby allowing for the 17,20-lyase activity of CYP17A1.[1] [2] [3] The condition affects both adrenal and gonadal androgen biosynthesis and results in male pseudohermaphroditism. The principal biological role of cytochrome b5 is reduction of methemoglobin, so cytochrome b5 deficiency can also result in elevated methemoglobin levels and/or methemoglobinemia, similarly to deficiency of cytochrome b5 reductase (methemoglobin reductase).

External links

Notes and References

  1. Book: Mark A. Sperling. Pediatric Endocrinology E-Book. 10 April 2014. Elsevier Health Sciences. 978-1-4557-5973-6. 498–.
  2. Mansouri A, Lurie AA . Concise review: methemoglobinemia . Am. J. Hematol. . 42 . 1 . 7–12 . January 1993 . 8416301 . 10.1002/ajh.2830420104 . 221426714 .
  3. Congenital methemoglobinemia with cytochrome b5 deficiency . N. Engl. J. Med. . 315 . 14 . 893–4 . October 1986 . 3748110 . 10.1056/NEJM198610023151415 .